Rifalazil treats and prevents relapse of clostridium difficile-associated diarrhea in hamsters

Antimicrobial Agents and Chemotherapy
Pauline M AntonCharalabos Pothoulakis

Abstract

Although vancomycin and metronidazole effectively treat Clostridium difficile-associated diarrhea and colitis (CDAD), their use is associated with a high incidence of relapsing C. difficile infection. Rifalazil is a new benzoxazinorifamycin that possesses activity against Mycobacterium tuberculosis and gram-positive bacteria. Here we compared rifalazil and vancomycin for effectiveness in preventing or treating clindamycin-induced cecitis in a hamster model of CDAD. Golden Syrian hamsters were injected subcutaneously with clindamycin phosphate (10 mg/kg), followed 24 h later by C. difficile gavage. Hamsters received by gavage for 5 days vehicle, vancomycin (50 mg/kg), or rifalazil (20 mg/kg) either simultaneously with (prophylactic protocol) or 24 h after C. difficile administration (treatment protocol). While all vehicle-administered animals became moribund within 48 h of C. difficile administration, no rifalazil- or vancomycin-treated animals in either protocol showed signs of morbidity after 7 days. Ceca of rifalazil-treated animals showed absence of epithelial cell damage, significantly reduced congestion and edema, and less, but not statistically significantly less, neutrophil infiltration compared to those of vehicle-treat...Continue Reading

References

Nov 1, 1977·The Journal of Infectious Diseases·J G BartlettD L Kasper
Mar 1, 1984·Reviews of Infectious Diseases·J G Bartlett
Jul 1, 1995·Antimicrobial Agents and Chemotherapy·K FujiiK Hosoe
Feb 1, 1994·Proceedings of the National Academy of Sciences of the United States of America·C PothoulakisS E Leeman
Jun 1, 1994·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·M M OlsonD N Gerding
Feb 1, 1995·Antimicrobial Agents and Chemotherapy·J Luna-HerreraP R Gangadharam
Jan 27, 1994·The New England Journal of Medicine·C P KellyJ T LaMont
Feb 1, 1996·Antimicrobial Agents and Chemotherapy·S P Klemens, M H Cynamon
Dec 1, 1996·Antimicrobial Agents and Chemotherapy·K HosoeT Ohashi
Oct 6, 1997·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·K K LaiS Baker
Apr 2, 1998·The Journal of Hospital Infection·M H WilcoxA Davidson
Feb 2, 1999·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·L V McFarlandR N Greenberg
May 1, 1999·Antimicrobial Agents and Chemotherapy·J K AkadaT Nakazawa
Dec 22, 1999·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·T MaeT Hidaka
Feb 5, 2000·The Journal of Hospital Infection·M H Samore
Aug 22, 2000·Antimicrobial Agents and Chemotherapy·C S McVay, R D Rolfe
Feb 24, 2001·American Journal of Physiology. Gastrointestinal and Liver Physiology·C Pothoulakis, J T Lamont
Jun 20, 2001·Gut·L Kyne, C P Kelly
Oct 6, 2001·Gastroenterology Clinics of North America·L KyneC P Kelly
Jul 24, 2002·The American Journal of Gastroenterology·Lynne V McFarlandChristina M Surawicz
Jan 31, 2003·Expert Opinion on Investigational Drugs·David M RothsteinBarry I Eisenstein
Aug 2, 2003·Gastroenterology·Tor C SavidgeCharalabos Pothoulakis
Sep 1, 1949·The Journal of Clinical Investigation·J C LewisW D Maclay

❮ Previous
Next ❯

Citations

Feb 10, 2012·Journal of Medicinal Chemistry·Matthew J LaMarcheQingming Zhu
Feb 7, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dale N GerdingRobert C Owens
Jun 10, 2009·British Medical Bulletin·O Martin Williams, Robert C Spencer
Dec 25, 2012·The Journal of Antimicrobial Chemotherapy·Xiaoqian WuJulian G Hurdle
Aug 8, 2012·Antimicrobial Agents and Chemotherapy·Manoj KumarPradip K Bhatnagar
Jun 27, 2012·Antimicrobial Agents and Chemotherapy·Michelle M ButlerTerry L Bowlin
May 31, 2012·Antimicrobial Agents and Chemotherapy·Anna TrzaskoDavid McKenney
Jul 1, 2010·Toxins·Xingmin SunHanping Feng
Oct 17, 2008·Expert Opinion on Investigational Drugs·Joseph GuilesXicheng Sun
May 31, 2006·Expert Opinion on Investigational Drugs·David M RothsteinLee Ann Campbell
Jun 5, 2010·Expert Opinion on Investigational Drugs·Hoonmo L KooHerbert L Dupont
Aug 10, 2012·Advances in Surgery·Ibrahim NassourBrian S Zuckerbraun
Mar 12, 2015·Journal of Medicinal Chemistry·Angie M JarradMatthew A Cooper
Mar 14, 2009·The Surgical Clinics of North America·Philip A Efron, John E Mazuski
Oct 14, 2008·Gastroenterology·Xinhua ChenCiarán P Kelly
Jun 5, 2007·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Kianoosh KatcharCiarán P Kelly
May 5, 2012·Gut Microbes·Emma L BestMark H Wilcox
Dec 3, 2016·Infectious Diseases and Therapy·Csaba FehérJosep Mensa
Dec 7, 2006·The Annals of Pharmacotherapy·Dorothy SurowiecCristina E Cicogna
Apr 24, 2008·The Annals of Pharmacotherapy·Kevin W GareyHerbert L DuPont
Jul 18, 2018·Antimicrobial Agents and Chemotherapy·Amber HowertonErnesto Abel-Santos
May 12, 2010·Expert Review of Anti-infective Therapy·Dhara ShahKevin W Garey
Jan 15, 2014·Expert Review of Anti-infective Therapy·Ardeshir RinehMichael R Hamblin
Aug 31, 2015·GE Portuguese Journal of Gastroenterology·Joana CarmoCristina Chagas
Mar 31, 2021·Scientific Reports·Nader S Abutaleb, Mohamed N Seleem

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.